Norges Bank
ANAB icon

Norges Bank’s AnaptysBio ANAB Stock Holding History

Norges Bank’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-151,538
Closed -$2.46M – 2050
2019
Q4 		$2.46M Sell
151,538
-94,107
-38% -$2.23M ﹤0.01% 1967
2019
Q3 		$8.6M Buy
245,645
+43,819
+22% +$2.08M ﹤0.01% 1823
2019
Q2 		$11.4M Buy
201,826
+56,836
+39% +$4.09M ﹤0.01% 1761
2019
Q1 		$10.6M Buy
144,990
+28,785
+25% +$1.99M ﹤0.01% 1782
2018
Q4 		$7.41M Hold
116,205
– – ﹤0.01% 1830
2018
Q3 		$11.6M Buy
116,205
+50,000
+76% +$4.15M ﹤0.01% 1769
2018
Q2 		$4.7M Sell
66,205
-56,995
-46% -$4.78M ﹤0.01% 1962
2018
Q1 		$12.8M Buy
+123,200
New +$13.9M ﹤0.01% 1655

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Norges Bank's ANAB Position: Q1 2020 in Review

Norges Bank sold out of AnaptysBio (ANAB) in Q1 2020, closing a stake of 151,538 shares — an estimated $2.46M sold.

Norges Bank first reported a position in ANAB in Q1 2018 and held it in 8 quarters. The position peaked at $12.8M in Q1 2018. 116 funds tracked by Wall St. Rank hold ANAB as of Q1 2020.

  • Norges Bank reported no remaining AnaptysBio position as of Q1 2020 after selling out during the quarter.
  • Norges Bank sold 151,538 AnaptysBio shares in Q1 2020, an estimated $2.46M.
  • Norges Bank first reported a position in AnaptysBio in Q1 2018 and held it in 8 quarters.
  • Norges Bank's AnaptysBio position peaked at $12.8M in Q1 2018.
  • 116 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2020.

Based on Norges Bank's 13F filing for Q1 2020, filed 8 May 2020.